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The major susceptibility locus for psoriasis, PSORS1,
resides on chromosome 6p and includes the candidate
genes HLA-C, HCR, and CDSN. Based on a nation-
wide collection of psoriasis patients and genotyping
for the PSORS1 susceptibility haplotype, we selected
for a genome scan nine families who do not show asso-
ciation with PSORS1 to more easily detect minor loci
for psoriasis susceptibility. In the genome scan, ¢ve loci
gave initial evidence of linkage and were studied with a
denser marker map. After ¢ne mapping, only one locus
on 18p11.23 showed suggestive evidence of linkage
(nonparametric multipoint linkage analysis score, 3.58;
p¼ 0.0038). The bootstrapping analysis showed that one
large family contributed the majority of the linkage
(p¼ 0.0039), but was supported by other families. Hap-
lotype sharing between the linked families and haplo-
type association analysis gave additional support for
the locus. Further, the 18p locus has shown nominal
evidence of linkage with psoriasis in the British popu-
lation. Taken together, these ¢ndings con¢rm the
presence of a minor susceptibility locus for psoriasis on
18p11. Keywords: multifactorial disease/genetic mapping/
linkage analysis/skin. J Invest Dermatol 121:735 ^740, 2003
P
soriasis (OMIM#177900) is a chronic in£ammatory
skin disease. The disease occurs on all continents, with
a peak prevalence of 2%^3% observed in North Eur-
opeans (Christophers, 2001). The skin lesions are char-
acterized by abnormal proliferation and di¡erentiation
of keratinocytes, angiogenesis, and mixed leukocytic in¢ltrate of
T cells, neutrophils, and mast cells (Barker, 1991), but the exact
molecular pathogenesis of psoriasis is still largely unknown.
The multifactorial etiology of psoriasis is well established. Fa-
mily studies show a strong genetic component in psoriasis
susceptibility (Lomholt, 1963; Swanbeck et al, 1997). The concor-
dance rate among monozygotic twins is 65%^73% compared to
15%^23% in dizygotic twins, making the estimated overall her-
itability about 90% (Farber et al, 1974; Brandrup et al, 1978, 1982).
Environmental factors, however, are also needed to trigger the
disease in genetically susceptible individuals (Krueger and Duvic,
1994).
To ¢nd the genes controlling susceptibility to psoriasis, several
genomewide linkage studies have been published during the past
8 y. Numerous putative susceptibility loci have emerged in the
scans, but the replication of the results has proved di⁄cult, as seen
also in other complex diseases (Altmuller et al, 2001). One locus,
however, namely PSORS1, on chromosome 6p21.3, has been
replicated in several di¡erent populations (Nair et al, 1997; Trem-
bath et al, 1997; Burden et al, 1998; Samuelsson et al, 1999; Lee et al,
2000; Veal et al, 2001) and can thus be considered as the major
susceptibility locus for psoriasis. Other susceptibility loci that
have gained a LOD score 43 in at least one study are PSORS2
at 17q25 (Tomfohrde et al, 1994; Nair et al, 1997), PSORS3 at 4q34
(Matthews et al, 1996), PSORS4 at 1q (Capon et al, 1999), PSORS5
at 3q21 (Enlund et al, 1999), PSORS6 at 19p13 (Lee et al, 2000),
and PSORS7 at 1p (Veal et al, 2001). In addition to the named
PSORS loci, several other suggestive susceptibility loci have also
been published, for example, 16q (Nair et al, 1997) and 20p (Nair
et al, 1997; Trembath et al, 1997).
The signi¢cance of PSORS1 in the MHC region has been
further established in several association studies of three tightly
linked susceptibility alleles: HLA-Cw6 (Tiilikainen et al, 1980;
Enerback et al, 1997; Mallon et al, 1997), HCRWWCC (Asuma-
lahti et al, 2000, 2002), and CDSN5 (Ishihara et al, 1996; Allen
et al, 1999; Jenisch et al, 1999). Based on the association and linkage
studies, the PSORS1 locus seems to explain 30%^50% of psoria-
sis. Other, minor susceptibility loci are thus likely to exist. The
detection of the minor loci has, however, proved di⁄cult because
of locus heterogeneity, which makes the replication of the linkage
di⁄cult in di¡erent ethnic groups (Capon et al, 2002).
The aim of this study was to search for additional psoriasis sus-
ceptibility loci in Finnish multiplex psoriasis families by a geno-
mewide linkage approach while trying to minimize the
overwhelming e¡ect of the PSORS1 locus. The families were
¢rst genotyped for PSORS1 and only families who did not
show linkage and association to PSORS1 were selected for the
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genomewide scan. Our results support a locus for psoriasis sus-
ceptibility on chromosome 18p11.
METHODS
Patient material and selection of families We recruited 31 Finnish
multiplex families with at least three psoriasis patients per family (on
average 3.9 a¡ected per family; range, 3^10). Altogether we collected
samples and data from 227 individuals of whom 121 were a¡ected. The
sample collection was approved by the ethical review boards of all
participating hospitals and the Department of Medical Genetics,
University of Helsinki, and all samples were used by informed consent.
The age of psoriasis onset varied between 7 and 80 y (mean, 29.6 y;
median, 27.5 y), and the age at sample collection of the patients was
between 12 and 89 y (mean, 46.4 y; median, 47 y). In recruiting the
families, the inclusion criteria for the probands were that they were under
40 y of age and had chronic plaque psoriasis. Relatives with psoriasis were
included irrespective of their age of onset or type of psoriasis; altogether
79% of all patients had plaque psoriasis.
To select for PSORS1-negative families for a genome scan, all study
subjects were genotyped for two SNP in the HCR gene (HCR-325 and
HCR-1723) by using PCR ampli¢cation and altered restriction sites forAvaII
and MslI, respectively, as described previously (Asumalahti et al, 2002). Based
on PSORS1 status, nine families were selected for the genomewide scan. In
the selected families 89% of the patients had plaque psoriasis.
Genome scan The genome scan was performed using 377 £uorescently
labeled polymorphic microsatellite markers from a linkage mapping set
(MD-10, Applied Biosystems, Foster City, CA). The average interval
between the markers was 9.1 cM. The overall success rate for genotyping
was 95.4%. PCR assays were performed in 5-ml volumes containing
20 ng of DNA, with reagent concentrations and temperature pro¢les
as recommended by the reagent manufacturer (Applied Biosystems). The
electrophoreses were run using Megabace 1000 capillary instruments
(Molecular Dynamics, Sunnyvale, CA), and allele calling was carried out
using the Genetic Pro¢ler 1.1 (Molecular Dynamics) software.
Fine mapping To increase the marker density to 5 cM in loci
with nominal evidence of linkage (3p, 11p, 12p, 15q, 18p, and 22q), we
genotyped a total of 23 additional microsatellite markers. On 18p11, ¢ne
mapping was continued with 10 more markers to a density of
approximately 1 cM between markers. The ¢ne mapping markers
were selected from the Genethon (ftp://ftp.genethon.fr/pub/gmap/) and
Marsh¢eld (http://research.marsh¢eldclinic.org/genetics/) genetic maps.
The order and physical distance of the markers on 18p11 were con¢rmed
from the NCBI (http://www.ncbi.nlm.nih.gov/) and Celera public
databases (http://public.celera.com/). Fluorescently labeled PCR products
were run on an ABI 377 sequencer. Allele calling was carried out using
Genotyper 2.0 (Applied Biosystems).
Statistical analysis To analyze genomewide linkage, nonparametric
multipoint linkage analysis (NPL) was performed using GeneHunter 2.1
(Kruglyak et al, 1996). No further selection or multiple testing was applied
at the analysis stage, and thus our analysis constitutes a test whether there is
a locus (loci) contributing to the psoriasis phenotype in these families.
Association analysis on chromosome 18p was performed using the
haplotype pattern mining algorithm (Toivonen et al, 2000). Haplotype
pattern mining is a data-mining-based method that searches for genetic
association by detecting haplotype patterns that are disease associated
using a w2 test. Haplotyping was performed in trios formed from the
large pedigrees with an in-house computer program that ¢nds a maximal
number of independent trios with di¡erent chromosomes. A chromosome
was considered as trait-associated if it occurred in any of the a¡ected family
members and as control if it occurred only in una¡ected individuals.
RESULTS
Selection of the families for the genomewide scan To
choose families for a genome scan, we ¢rst genotyped all study
subjects for two HCR SNP. PSORS1-positive individuals were
de¢ned as those having the alleles HCR-325T and HCR-
1723T, and PSORS1-negative all those with other allele
combinations (CG, CT, and TG, respectively). This is a
conservative de¢nition for the PSORS1 locus, because nearly all
subjects positive for these alleles are also HLA-Cw6-positive,
whereas a selection of patients negative for HLA-Cw6 would
still include many positive for the HCR susceptibility allele
(Asumalahti et al, 2002). Based on our previous results, HCR-
325T and HCR-1723T are also in strong (98.3%) linkage
disequilibrium with each other and with the other two SNP
comprising the psoriasis susceptibility haplotype HCRWWCC
(Asumalahti et al, 2002). Seventy-one percent (86 of 121) of
patients and 22% (21 of 96) of una¡ected family members were
PSORS1-positive according to our de¢nition.
To ¢nally select the families for the genome scan, a PSORS1-
negative family was de¢ned as having more than two PSORS1-
negative patients and at least one transmission of psoriasis from
parent to o¡spring without cotransmission of PSORS1. Nine
families (altogether 77 individuals, 37 a¡ected) ful¢lled these
selection criteria and were included in the genomewide scan
(Fig 1). In the selected nine families, 70% (26 of 37) of the
patients were PSORS1-negative.
Genomewide scan A total of ¢ve loci showed some evidence
of linkage for psoriasis (NPL score, 41.7) (Fig 2). The regions
were chromosome 11p between markers D11S1338 and D11S904
(NPL score, 1.82; p¼ 0.040), 12q between D12S364 and D12S368
(NPL score, 1.76; p¼ 0.044), 15q between D15S1007 and D15S117
(NPL score, 1.93; p¼ 0.034), 18p between D18S63 and D18S464
(NPL score, 1.72; p¼ 0.046), and 22q between D22S280 and
D22S423 (NPL score, 2.19; p¼ 0.023) (Fig 2). As expected,
PSORS1 at 6p showed negative NPL scores. The other known
PSORS loci showed no strong evidence of linkage (NPL scores
ranging from ^0.5 to 0.6) in this sample, with the exception of
chromosome 3p, where a NPL score of 1.21 was observed
between markers D3S1566 and D3S1278, 10 cM from the
PSORS5 locus.
Fine mapping We selected six loci (3p, 11p, 12q, 15q, 18p, and
22q) for ¢ne mapping with a total of 23 microsatellite markers
to increase the marker density. The NPL scores remained
essentially unchanged or decreased for all the other loci but 18p.
On 18p11, the NPL score increased sharply to 3.50 (p¼ 0.0045).
Next we added 9 more markers into the interval between the
markers D18S63 and D18464 to increase the marker density to
approximately 1 cM between markers and repeated the linkage
analysis (Fig 3). The NPL score increased further to 3.58
(p¼ 0.0038) between markers D18S63 and D18S967 (with 9
markers typed within the interval). According to the publicly
available human genomic sequence, the distance between these
two markers is approximately 3.2 Mb. On the other hand,
genetic maps estimated the distance between the £anking
markers to be approximately 11 cM and showed discrepancy in
the order of the markers even when the Marsh¢eld, Genethon,
Cedar (http://cedar.genetics.soton.ac.uk/pub), and deCode (at map
viewer http://www.ncbi.nlm.nih.gov/) maps were compared.
For our analyses, we ordered the markers according to the
physical map.
To analyze the robustness of linkage, we used bootstrapping
and calculated linkage by leaving one family at a time of the
analysis. In eight of nine such analyses, the linkage remained
essentially unchanged, whereas family 3 seemed to contribute
the majority of the linkage information (Table I). We then
reanalyzed genomewide linkage separately for this family and
found that the peak at chromosome 18p is by far the strongest
genetic e¡ect (p¼ 0.0039), with the next best loci in
chromosomes 22 (p¼ 0.006) and 1, 5, and 6q (p¼ 0.031).
Analysis of linkage by including only the markers used in
a previous study with a possible linkage in the same locus (Veal
et al, 2001) yielded a similarly shaped linkage result with a NPL
score of 0.5 at D18S59 (data not shown).
To compare the observed linkage in 14 informative families
positive for PSORS1 and not included in the genome scan,
we genotyped the markers D18S59, D18S471, D18S967, and
D18S1150. The linkage result was negative (NPL scores from
^0.8 to ^1.6 across the interval).
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Association analysis on 18p11 To explore the possibility of a
shared ancestry between families, we next studied haplotype
sharing between the families. All patients in families 3, 7, and 8
who showed the strongest linkage to 18p11 (NPL scores, 10.5,
2.4, and 1.9, respectively) shared the D18S4712 allele. In addi-
tion, two of the families shared a three-marker haplotype
(D18S4582-D18S4712-AFM238yg31) across the £anking markers
(Fig 3).
We next used the haplotype pattern mining algorithm to
detect the best-associated haplotype patterns. The best associa-
tion was found for a three-marker haplotype (D18S4712-
AFM238yg31-D18S9674) that overlapped with the haplotype
shared between the largest linked families. This haplotype was
found on 6 of 30 of patients’ chromosomes but 0 of 26 of
control chromosomes (p¼ 0.025; Fig 3).
DISCUSSION
PSORS1 on chromosome 6p21.3 is the only repeatedly observed
locus to explain genetic susceptibility to psoriasis. Even this ma-
jor locus, however, seems to explain only about 30%^50% of
psoriasis cases and minor susceptibility loci are likely to exist. In-
deed, at least seven candidate loci have been mapped so far.
We have performed a genomewide scan in a selected set of
PSORS1-negative psoriasis families from Finland to assess the
role of other loci in familial psoriasis. Surprisingly, our results
yielded the strongest evidence of linkage for a new susceptibility
locus.
A major e¡ect of PSORS1 was excluded by genotyping two
HCR SNP (HCR-325 and HCR-1723) of the HCRWWCC
susceptibility allele. The two SNP are in strong linkage disequili-
brium with each other and the other two risk SNP. In our pre-
vious study of 1680 chromosomes from several populations
(Asumalahti et al, 2002), the HCRWWCC allele was in very
strong linkage disequilibrium also with both the HLA-Cw6
and the CDSN5 risk alleles. By genotyping just the two HCR
SNP we could conservatively select families where PSORS1
must play a minor role. Consistent with the selection of families,
PSORS1 yielded negative NPL scores in our linkage analyses
(Fig 2).
The PSORS1 locus has previously been shown to associate
especially with familial background and early age of onset of
psoriasis (Henseler and Christophers, 1985; Swanbeck et al, 1995).
This was the case also in our family material: in only 3 of 31 mul-
tiplex families, there were no patients with the PSORS1 suscept-
ibility allele. Six additional families ful¢lled our selection criteria
for PSORS1-negative families and altogether nine families were
included in the genomewide scan. After the initial selection of
families, no further selection or alternative linkage models were
applied. Therefore, our linkage analysis requires no adjustment
for signi¢cance thresholds.
In the genome scan, ¢ve loci gave initial evidence of linkage in
NPL (1.72^2.19) and one locus (with NPL score, 1.21) was located
10 cM from PSORS5. After increasing the marker density to 5
cM, only one locus, on 18p11.23, showed suggestive evidence of
linkage (NPL score, 3.50; p¼ 0.0045). At the other loci, NPL
scores did not increase or even decreased, when the information
of additional markers was added. This is expected for spurious or
false peaks. A further increase of marker density to approximately
1 cM between markers yielded a NPL peak of 3.58 (p¼ 0.0038).
A bootstrapping analysis indicated that the linkage was most
Figure1. Pedigree structures of the nine genome scan families. DNA samples from the numbered individuals were available in the analysis. Gray,
uncertain diagnosis; coded as unknown in the analyses. Black dot, PSORS1-negative individuals.
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strongly supported by one family (Fig 1, Fam 3). An analysis of
PSORS1-positive families who were excluded from the genome
scan yielded negative NPL scores across the 18p locus.
Haplotype sharing between the linked families gave additional
support for the locus. Association analysis showed evidence of
association for a three-marker haplotype (D18S4712-
AFM238yg31-D18S9674) just over the NPL peak. The number
of independent chromosomes was quite small (30 a¡ected and 26
control chromosomes), and the statistical evidence for the associa-
tion remained rather weak (p¼ 0.025). All patients in the linked
families, however, shared the D18S4712 allele. In addition, two
families shared a three-marker haplotype. Because the D18S4712
allele was the major allele with a frequency of 0.54, it did not
yield statistical signi¢cance for allele association alone.
There was some discrepancy in the marker order between the
di¡erent genetic maps on the NPL peak. The genetic distance be-
tween the markers was zero based on the sex-average maps. No
recombinations were observed between the markers and thus
Figure 2. Nonparametric linkage analysis results performed using GeneHunter. Solid lines, NPL curves (scale on the left y-axis); dotted lines, informa-
tion content curves (scale on the right y-axis). The locations of PSORS1-7 loci are marked below curves. Dashed lines under ¢gures, six ¢ne mapping loci.
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the intermarker order did not a¡ect the overall NPL score. We
ordered the markers based on the sequence data. The two over-
lapping haplotypes covered an approximately 700-kb region.
One previous study on psoriasis sibling pairs from the British
population has previously yielded nominal evidence of linkage
and excess allele sharing on chromosome 18p (NPL score, 1.97;
p¼ 0.025) (Veal et al, 2001). They reported nominally signi¢cant
p values for two markers interpreted as interesting, D18S59 (at
1.39 cM on the deCode linkage map) and D18S1150 (at 33.55
cM).We included the same markers used by Veal et al (2001) to
our analyses for full consistency. Our linkage peak is entirely
within this region of interest, with the shared three-marker hap-
lotype spanning from D18S471 (at 18.37 cM) to D18S967 (at 21.24
cM). Interestingly, when we calculated linkage in our families
using only the same markers asVeal et al (2001), the shape of link-
age peak was similar with peak at D18S59 in both sets. Thus, the
linkage results are fully consistent for location. Our report and
that of Veal et al (2001) together constitute su⁄cient evidence
for a con¢rmed psoriasis susceptibility locus on 18p. In addition,
the 18p locus has recently been reported also as a susceptibility
locus for atopic disease. In the Swedish population, extreme
atopic disease phenotype showed most prominent multipoint
linkage to 18p (LOD score, 1.88; po0.05) (Bradley et al, 2002).
Psoriasis and atopic disease share also other susceptibility regions,
on 1q21, 3q21, 17q25, and 20p (Cookson et al, 2001), suggesting
that genes at these loci might have general e¡ects on dermal in-
£ammation and immunity. No con¢rmed genes are located in
the 18p susceptibility region. Several putative genes are, however,
predicted in the region, and some of them are supported by EST,
but no expression data are currently available.
We have presented here a genomewide scan in psoriasis per-
formed only in PSORS1-negative families. Of note, most pre-
vious genome scans have included families that have a strong
contribution by the PSORS1 locus, whereas this study concen-
trates on families without PSORS1 e¡ect. Thus, the di¡erent
genome scan results may also re£ect in part PSORS1-interacting
and PSORS1-independent loci.We found evidence of a suscept-
ibility locus for psoriasis at 18p11 (NPL score, 3.6), which was
further supported with a suggestive haplotype association. To-
gether with data reported by Veal et al (2001), our ¢ndings con-
¢rm the presence of a minor locus for psoriasis susceptibility on
chromosome 18p11.
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